PCN34 PHARMAECONOMIC EVALUATION OF THE USE OF ERLOTINIB IN NON-SMALL CELLS LUNG CANCER (NSCLC) WITH FAILURE TO PREVIOUS CHEMOTHERAPY
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66571-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)66571-0/fulltext
Section Title :
Section Order :
406
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66571-0&doi=10.1016/S1098-3015(10)66571-0